Becton Dickinson and Company (NYSE: BDX), San Diego, CA – FDA Inspections
Inspection records and compliance data for Becton Dickinson and Company in San Diego, California. 3 FDA inspections on record, last inspected April 16, 2026. Publicly traded as NYSE: BDX.
This profile covers Becton Dickinson and Company based in San Diego, California, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected July 24, 2019. Last inspected April 16, 2026.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 16, 2026 | Not classified | Medical Devices & Rad Health | 1318176 |
| January 11, 2023 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 1195228 |
| July 24, 2019 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 1101683 |
No Form 483s, Warning Letters or EIRs on record.
Companies with similar regulatory profiles, compliance history, and operations.
Name
Becton Dickinson and Company
Stock ticker
BDX
Exchange
NYSE
Share price
$213.24
Market cap
$58.1B
Price as of
November 6, 2026
FEI Number
3007886372
Address
10865 Road To The Cure Ste 200, San Diego, California 92121, United States
Country
United States
ID: d223a3bd-0833-4b08-b4cd-36335f36590c